Articolul precedent |
Articolul urmator |
328 3 |
Ultima descărcare din IBN: 2022-10-18 20:00 |
SM ISO690:2012 BACALIM, Lilia, GHIDIRIM, Nicolae, SOFRONI, Larisa, CHILARU (CHIABURU), Simona, ODOBESCU, Oxana, ŞCHIOPU, Victor. Riscul de progresare al cancerului mamar LUM A vs. LUM B. In: Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”, 21-23 octombrie 2020, Chişinău. Chişinău: USMF, 2020, p. 588. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” 2020 | ||||||
Congresul "Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”" Chişinău, Moldova, 21-23 octombrie 2020 | ||||||
|
||||||
Pag. 588-588 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Background. Malignant breast tumors in women younger than 45 years tend to have features that are characteristic of more aggressive or advanced tumors compared with tumors in older women. These tumor variables have been associated with poorer overall survival Objective of the study. Comparative analysis of the progression risk of breast cancer subtype LUM A vs. LUM B in young patients after complex treatment Material and Methods. In the study were enrolled 120 patients with CGM who were treated in the Mammology Laboratory, Chemotherapy and Radiotherapy Departments of the Oncological Institute in the Republic of Moldova. Enrolled participants were divided into lots according to the luminal subtype. Thus, 68 (56.6%) of patients were LUMA and 52 (43.3%) -LUM B. Results. LUM A tumors showed much more favorable results on the evolution, complex treatment outcomes and disease prognosis compared with LUM B. The progression of the disease found in LUMA in 26.4% vs. 36.6% - for LUM B (p˂0.05).The most frequent localization of metastases was pulmonary (№=19;34,0%), bone (№=16;28,5%), ovarian (№=11;19,6%) and liver (№=10;17,8%). Conclusion. Luminal subtypes determine significantly the evolution and prognosis of CGM. LUM B tumors showed much more progresion cases compared with LUM A. |
||||||
Cuvinte-cheie breast cancer, luminal subtype, progression, cancer mamar, subtip luminal, progresare |
||||||
|